AVITA Medical Inc (ASX: AVH)

AVITA Medical, Inc. is a commercial-stage regenerative medicine company. The Company is a provider of regenerative medicine addressing unmet medical needs in burn injuries, full-thickness skin defects, and in skin repigmentation, such as vitiligo.

Its RECELL platform a single use, stand-alone, battery operated, autologous cell harvesting device containing enzymatic and buffer solutions, sterile surgical instruments, and actuators. RECELL is used for the treatment of thermal burn wounds and full-thickness skin defects, and for repigmentation of stable depigmented vitiligo lesions.

The platform technology of the RECELL System enables a thin split-thickness skin sample from the patient to be processed and prepared, producing an autologous cellular suspension called Spray-On Skin Cells. These Spray-On Skin Cells are prepared at the point of care in as little as 30 minutes, providing a new way to treat thermal burn wounds and full-thickness skin defects.

Top Australian Brokers

City Index - Aussie shares from $5 - Read our review
Pepperstone - Trading education - Read our review
IC Markets - Experienced and highly regulated - Read our review
eToro - Social and copy trading platform - Read our review

REVENUE IN AUD (TTM)

16.23m

NET INCOME IN AUD

-40.56m

Year on year AVITA Medical Inc had net income fall 112.85% from a loss of 16.52m to a larger loss of 35.16m despite a 543.96% increase in revenues from 1.27m to 8.16m.